Drug Makers' Compassionate Use Postings Doubled Since September 2016

The number of companies that post an easily viewable compassionate use policy has more than doubled since September 2016, according to a study by Avalere. The study comes months after Congress passed the 21st Century Cures Act, which contained a provision requiring manufacturers to post certain compassionate use policy information. In September 2016, Avalere found that only 19 percent of companies posted compassionate use policies in a survey of 100 websites of publicly traded pharmaceutical and biotechnology companies. Of the...